Paper19187
Clinical consequences of polymorphic acetylation of basic drugs.
Drayer DE and 1 other. Clin Pharmacol Ther, 1977. Cited by 150 papers, by iCite.
Cite this record
ConductScience Library. Clinical consequences of polymorphic acetylation of basic drugs. Papers, record 19187. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19187
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pharmaceutical Preparations | Major topic |
| Polymorphism, Genetic | Major topic |
| Acetylation | |
| Antibodies, Antinuclear | |
| Biotransformation | |
| Chemical and Drug Induced Liver Injury | |
| Humans | |
| Hydralazine | |
| Isoniazid | |
| Lupus Erythematosus, Systemic | |
| Phenelzine | |
| Phenotype | |
| Procainamide | |
| Sulfasalazine |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31964788 | N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31964788 | PubMed |
| 24467436 | Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24467436 | PubMed |
| 19968662 | Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. | Clin Exp Immunol | 2010 | https://conductscience.org/library/papers/19968662 | PubMed |
| 15568141 | The effects of acute ethanol intake on isoniazid pharmacokinetics. | Eur J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/15568141 | PubMed |
| 12844326 | Therapeutic drug monitoring of antiarrhythmic drugs. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12844326 | PubMed |
| 10225813 | Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years. | Ann Rheum Dis | 1999 | https://conductscience.org/library/papers/10225813 | PubMed |
| 9131488 | N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism. | J Pharmacokinet Biopharm | 1996 | https://conductscience.org/library/papers/9131488 | PubMed |
| 8261714 | Individual variation in first-pass metabolism. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8261714 | PubMed |
| 8103355 | Clinical significance of genetic influences on cardiovascular drug metabolism. | Cardiovasc Drugs Ther | 1993 | https://conductscience.org/library/papers/8103355 | PubMed |
| 7247454 | Hepatic acetylator phenotype in porphyria cutanea tarda. | Arch Dermatol Res | 1981 | https://conductscience.org/library/papers/7247454 | PubMed |
| 7059437 | A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7059437 | PubMed |
| 7059436 | Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7059436 | PubMed |
| 7047041 | Clinical pharmacokinetics of hydralazine. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/7047041 | PubMed |
| 7037261 | Drug metabolites in renal failure: pharmacokinetic and clinical implications. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/7037261 | PubMed |
| 6951172 | Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6951172 | PubMed |
| 6759093 | Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations. | Drugs | 1982 | https://conductscience.org/library/papers/6759093 | PubMed |
| 6721993 | A rapid method for determination of acetylation phenotype using dapsone. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6721993 | PubMed |
| 6721992 | A simple test for acetylator phenotype using caffeine. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6721992 | PubMed |
| 6131820 | Acetylation, deacetylation and acyltransfer. | Environ Health Perspect | 1983 | https://conductscience.org/library/papers/6131820 | PubMed |
| 3882287 | Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/3882287 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19187
GET https://conductscience.org/api/papers/v1/19187/cited_by?page=2